Sec Form 3 Filing - Versant Venture Capital VI, L.P. @ Contineum Therapeutics, Inc. - 2024-04-04

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Versant Venture Capital VI, L.P. 2. Issuer Name and Ticker or Trading Symbol Contineum Therapeutics, Inc. [ CTNM] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) ONE SANSOME STREET, SUITE 1650 3. Date of Earliest Transaction (MM/DD/YY) 04/04/2024 (Street) SAN FRANCISCO, CA94104 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Class A Common Stock 375,535 D ( 1 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Series A Preferred Stock ( 2 ) ( 2 ) ( 2 ) Class A Common Stock 1,775,421 I See Footnote ( 3 ) Series B Preferred Stock ( 2 ) ( 2 ) ( 2 ) Class A Common Stock 418,641 I See Footnote ( 3 ) Series C Preferred Stock ( 2 ) ( 2 ) ( 2 ) Class A Common Stock 132,499 I See Footnote ( 3 ) Series A Preferred Stock ( 2 ) ( 2 ) ( 2 ) Class A Common Stock 11,183 I See Footnote ( 4 ) Series B Preferred Stock ( 2 ) ( 2 ) ( 2 ) Class A Common Stock 2,637 I See Footnote ( 4 ) Series C Preferred Stock ( 2 ) ( 2 ) ( 2 ) Class A Common Stock 834 I See Footnote ( 4 ) Series B Preferred Stock ( 2 ) ( 2 ) ( 2 ) Class A Common Stock 525,472 I See Footnote ( 5 ) Series C Preferred Stock ( 2 ) ( 2 ) ( 2 ) Class A Common Stock 333,334 I See Footnote ( 5 ) Series A-1 Preferred Stock ( 2 ) ( 2 ) ( 2 ) Class A Common Stock 1,423,119 D ( 1 ) Series B Preferred Stock ( 2 ) ( 2 ) ( 2 ) Class A Common Stock 317,988 D ( 1 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Versant Venture Capital VI, L.P. ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO, CA94104 X Versant Ventures VI GP, L.P. ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO, CA94104 X Versant Ventures VI GP-GP, LLC ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO, CA94104 X Versant Venture Capital IV, L.P. ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO, CA94104 X Versant Side Fund IV, L.P. ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO, CA94104 X Versant Ventures IV, LLC ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO, CA94104 X Versant Vantage I, L.P. ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO, CA94104 X Versant Vantage I GP, L.P. ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO, CA94104 X Versant Vantage I GP-GP, LLC ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO, CA94104 X Signatures Versant Venture Capital VI, L.P. By: Versant Ventures VI GP, L.P. Its: General Partner By: Versant Ventures VI GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer 04/04/2024 Signature of Reporting Person Date Versant Ventures VI GP, L.P., By: Versant Ventures VI GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer 04/04/2024 Signature of Reporting Person Date Versant Ventures VI GP-GP, LLC By: /s/ Max Eisenberg Its: Chief Operating Officer 04/04/2024 Signature of Reporting Person Date Versant Vantage I, L.P. By: Versant Vantage I GP, L.P. Its: General Partner By: Versant Vantage I GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer 04/04/2024 Signature of Reporting Person Date Versant Vantage I GP, L.P., By: Versant Vantage I GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer 04/04/2024 Signature of Reporting Person Date Versant Vantage I GP-GP, LLC By: /s/ Max Eisenberg Its: Chief Operating Officer 04/04/2024 Signature of Reporting Person Date Versant Venture Capital IV, L.P., By: Versant Ventures IV, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer 04/04/2024 Signature of Reporting Person Date Versant Side Fund IV, L.P., By: Versant Ventures IV, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer 04/04/2024 Signature of Reporting Person Date Versant Ventures IV, LLC By: /s/ Max Eisenberg Its: Chief Operating Officer 04/04/2024 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The shares are held directly by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP, L.P. ("VV VI GP") is the general partner of VVC VI, and Versant Ventures VI GP-GP, LLC ("VV VI GP-GP") is the general partner of VV VI GP. Each of VV VI GP-GP and VV VI GP disclaims beneficial ownership of the shares held by VVC VI, except to the extent of their respective pecuniary interests therein. ( 2 )Upon the closing of the Issuer's initial public offering (the "IPO"), each of the outstanding shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the "Preferred Stock"), will automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis for no additional consideration, in accordance with the provisions of the Issuer's amended and restated certificate of incorporation, with the exception of certain shares of the Preferred Stock, which the Reporting Persons herein may elect, prior to the closing of the IPO, to convert into shares of the Issuer's Class B common stock. The Preferred Stock has no expiration Date. ( 3 )The shares are held directly by Versant Venture Capital IV, L.P. ("VVC IV"). Versant Ventures IV, LLC ("VV IV GP") is the general partner of VVC IV and disclaims beneficial ownership of the shares held by VVC IV, except to the extent of its pecuniary interest therein. ( 4 )The shares are held directly by Versant Side Fund IV, L.P. ("VSF IV"). VV IV GP is the general partner of VSF IV and disclaims beneficial ownership of the shares held by VSF IV, except to the extent of its pecuniary interest therein. ( 5 )The shares are held directly by Versant Vantage I, L.P. ("VV I"). Versant Vantage I GP, L.P. ("VV I GP") is the general partner of VV I, and Versant Vantage I GP-GP, LLC ("VV I GP-GP") is the general partner of VV I GP. Each of VV I GP-GP and VV I GP disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.